GB1244453A - Nicotinate esters - Google Patents

Nicotinate esters

Info

Publication number
GB1244453A
GB1244453A GB837070A GB837070A GB1244453A GB 1244453 A GB1244453 A GB 1244453A GB 837070 A GB837070 A GB 837070A GB 837070 A GB837070 A GB 837070A GB 1244453 A GB1244453 A GB 1244453A
Authority
GB
United Kingdom
Prior art keywords
hypolipaemic
feb
compound
agents
nicotinate esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB837070A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1244453A publication Critical patent/GB1244453A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,244,453. Hypolipaemic medicines. ROUSSEL UCLAF. 20 Feb., 1970 [21 Feb., 1969], No. 8370/70. Heading A5B. [Also in Division C2] Pharmaceutical compositions with hypolipaemic activity when administered orally or parenterally comprise a compound I in which the wavy line indicates that said compound may be in either configuration and a diluent or carrier and optionally further hypolipaemic agents, hypocholesterolaemic agents, e.g. 22, 25-diuza-19-nor-cholestan-1,3,5(10)- trien-3-ol and/or anticoagulants such as phenylindane-dione.
GB837070A 1969-02-21 1970-02-20 Nicotinate esters Expired GB1244453A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6904459A FR2035754A1 (en) 1969-02-21 1969-02-21

Publications (1)

Publication Number Publication Date
GB1244453A true GB1244453A (en) 1971-09-02

Family

ID=9029434

Family Applications (1)

Application Number Title Priority Date Filing Date
GB837070A Expired GB1244453A (en) 1969-02-21 1970-02-20 Nicotinate esters

Country Status (7)

Country Link
AT (1) AT292001B (en)
BE (1) BE746237A (en)
CH (1) CH523252A (en)
DE (1) DE2007948A1 (en)
ES (1) ES376759A1 (en)
FR (1) FR2035754A1 (en)
GB (1) GB1244453A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168389B (en) * 1981-05-06 1987-05-20 Alfa Farmaceutici Spa ALCANDIOL DERIVATIVES WITH HYPOLIPIDEMIZING ACTIVITY, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Also Published As

Publication number Publication date
CH523252A (en) 1972-05-31
BE746237A (en) 1970-08-19
ES376759A1 (en) 1972-05-16
AT292001B (en) 1971-08-10
DE2007948A1 (en) 1970-09-17
FR2035754A1 (en) 1970-12-24

Similar Documents

Publication Publication Date Title
CA942753A (en) 5-azaspiro (2,4) heptane-4,6-diones
IE35209B1 (en) 3,4-dihydroisoquinoline derivatives
GB1244453A (en) Nicotinate esters
CA941375A (en) 1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same
CA928710A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
GB1355097A (en) Pesticidal and pharmaceutical compositions
CA845141A (en) 2-(3-hydroxy-5-hydroxymethyl-2-methyl-4-pyridyl)-tetrahydro-1,3-thiazine-4-carboxylic acid and the preparation thereof
CA827694A (en) 3,3'-dithiobis(3-azabicyclo(3.2.2)nonane)
JPS545982A (en) Carbostyryl derivatives
CA838088A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 5((.alpha.,.alpha.,.alpha.,-TRIFLUORO-M-TOLYLOXY)-METHYL)-2-OXAZOLIDINETHIONE
AU456901B2 (en) TETRAHYDRO-2H-INDENO 1,2-o PYRIDINES
CA824172A (en) 2,4'-diisocyanato dicyclohexylmethane
GB1296625A (en)
AU1650470A (en) 1, 1'methylene-bis-piperazine
CA851201A (en) Quinoline esters and quinoline thionesters, and processes for the preparation thereof
CA858561A (en) 2,4-DIBROMOPREGNANE-17.alpha.,21-DIOL-3,11,20-TRIONE-21-ACYLATE
CA855939A (en) Elevators for crops etc.
GB1477303A (en) Pharmaceutical compositions
AU454743B2 (en) New pharmaceutically active 1, 4 dihydropyridines
CA846832A (en) N,n'-diglycidyl compounds
CA923500A (en) N,n'-diacyl-hydrazine derivatives and a process for the preparation thereof
CA837623A (en) 1-pyridyl-1,2,3,4-tetrahydroisoquinoline
CA847905A (en) 1-pyridyl-1,2,3,4-tetrahydroisoquinoline
AU2042770A (en) TETRAHYDRO-2H-INDENO 1,2-o PYRIDINES
AU285565B2 (en) Pharmaceutical compositions comprising 2 or 4 - amino - 3,5 dihlobenzylamines